Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 26, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a skin cancer research…
Biotechnology | Cloning | Disease | Genomics | Life Science News | Medicine | Therapeutics
Moratorium on heritable genome editing published in Nature
On Mar. 13, 2019, Eric Lander, Franooise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg and specialists from seven…
The University of Alabama’s newest cancer-killing cyclotron was installed
On Mar. 5, 2019, Emma, the 90-ton cyclotron which is the centerpiece of the new proton therapy initiative…
Scientists described the first-ever successful in situ collection of a bacteria that eats and breathes electricity
On Mar. 5, 2019, scientists at Washington State University described the first-ever successful in situ collection of a…
Vaccitech awarded BARDA contract valued at $8.6 million to conduct phase II trial for influenza vaccine
On Mar. 4, 2019, Vaccitech announced that it had been awarded a contract valued at $8.6 million from…
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
ICON acquired MolecularMD
On Feb. 21, 2019, ICON announced that it had acquired MolecularMD, a molecular diagnostic specialty laboratory that enables…
CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness
On Feb. 15, 2019, the U.S. Centers for Disease Control and Prevention (CDC) published ACIP recommendations for use….
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
Ontario Institute for Cancer Research leukemia therapy discovery received approximately $1 billion in funding from Celgene
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
TESARO was acquired by GSK for $5.1 billion
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
Masonic Cancer Center researcher Branden Moriarity, PhD, received U24 Grant with Recombinetics, Inc
On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The…
Takeda Pharmaceutical acquired Shire
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for $62…
Emory University School of Medicine received a $500,000 grant from CDC to research children’s recovery from mild traumatic brain injury (mTBI)
On Jan. 7, 2019, the Emory University School of Medicine received a $500,000 grant from the Centers for…
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
The Allen Institute for Immunology was founded
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
A UCLA-led research team identified genetic processes involved in the neurodegeneration that occurs in dementiaï¾
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
University of South Carolina awarded CDC grant to study the risk of human exposure to environmental antibiotic resistant bacteria
On Nov. 30, 2018, Sean Norman, associate professor of environmental health sciences and director of the Molecular Microbial…